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Deposition of aggregated amyloid- (A) peptide in brain is an early event and hallmark pathology of Alzheimer’s disease and cerebral
A angiopathy. Experimental evidence supports the concept that A multimers can act as seeds and structurally corrupt other A
peptides by a self-propagatingmechanism. Here we compare the induction of cerebral-amyloidosis by intraperitoneal applications of
A-containing brain extracts in three A-precursor protein (APP) transgenicmouse lines that differ in levels of transgene expression in
brain and periphery (APP23mice, APP23mice lackingmurine APP, and R1.40 mice). Results revealed that beta-amyloidosis induction,
which could be blocked with an anti-A antibody, was dependent on the amount of inoculated brain extract and on the level of APP/A
expression in the brain but not in the periphery. The inducedAdeposits in brain occurred in a characteristic pattern consistentwith the
entry of A seeds at multiple brain locations. Intraperitoneally injected A could be detected in blood monocytes and some peripheral
tissues (liver, spleen) up to 30 d after the injection but escaped histological and biochemical detection thereafter. These results suggest
that intraperitoneally inoculated A seeds are transported from the periphery to the brain in which corruptive templating of host A
occurs at multiple sites, most efficiently in regions with high availability of soluble A.
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Introduction
Cerebral -amyloidosis, a hallmark of Alzheimer’s disease (AD),
can be exogenously induced by the intracerebral infusion of
-amyloid (A) containing brain extracts into young A-
precursor protein (APP) transgenic (Tg) mice (Kane et al., 2000;
Meyer-Luehmann et al., 2006; Eisele et al., 2009; Watts et al.,
2011; Hamaguchi et al., 2012; Morales et al., 2012; Rosen et al.,
2012). The beta-amyloidosis inducing activity has been shown to
consist of multimeric A peptides (Meyer-Luehmann et al.,
2006). Subsequent studies have demonstrated that aggregated
synthetic A is itself sufficient to induce cerebral -amyloidosis
although with lower biological activity than the A-containing
brain extracts (Sto¨hr et al., 2012). These observations are remi-
niscent of prion disorders such as Creutzfeldt-Jakob disease or
bovine spongiform encephalitis in which it is now established
beyond a reasonable doubt that these disorders can be transmit-
ted by exogenous, conformational variants of the prion protein
(PrP; Colby and Prusiner, 2011). It is currently hypothesized that
the self-replication of pathogenic protein aggregates (prion-like
misfolding of proteins) is a uniform principle responsible for the
instigation and spreading ofmany age-related neurodegenerative
disorders (Jucker and Walker, 2013).
We found previously that intraperitoneal applications of A-
containing brain extract can also induce cerebral -amyloidosis
in young APP23 Tg mice, albeit at a higher concentration and a
longer incubation interval compared to the intracerebral inocu-
lation route (Eisele et al., 2010). In APP23 Tgmice, expression of
human APP is primarily confined to neurons in the brain
(Sturchler-Pierrat et al., 1997), but murine APP is also expressed
in peripheral neuronal and non-neuronal tissues and may con-
tribute to peripheral seeding. From studies in the prion field, it is
known that the cellular PrP (PrPC) in peripheral cells plays a
crucial role in the transfer of the infectious prion (PrPSc) from the
periphery to the CNS (Bla¨ttler et al., 1997), and PrPSc accumu-
lates in some peripheral sites, such as lymphoid tissues, during its
transmission from the periphery to the brain (Mabbott and
MacPherson, 2006; Aguzzi et al., 2013).
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In the present study, we characterize the nature, mechanism,
and the time- and concentration-dependent intraperitoneal in-
duction of cerebral -amyloidosis. We compare APP23 mice as
hosts with a second Tg mouse strain, R1.40, that harbors a yeast
artificial chromosome containing a genomic copy of the human
APP gene. In R1.40mice, humanAPP is expressed not only in the
brain but also in the systemic organs, such as kidney, testes, and
heart, and reflects normal tissue-specific APP/A expression
(Lamb et al., 1997). As a complementary host system, we used
APP23mice bred on amurineApp-null background (Calhoun et
al., 1999), i.e., a host expressing only human APP in brain and
devoid of peripheral APP expression. The present study confirms
the concept of prion-like misfolding of A and suggests that A
seeds can be transported from distant locations to the brain in
which corruptive templating of host A occurs.
Materials andMethods
Mice.APP23 Tgmice (Sturchler-Pierrat et al., 1997) expressing a human
APP751 cDNA with the K670N–M671L mutation under control of the
murine Thy1.2 promoter were backcrossed with C57BL/6J mice for20
generations and maintained on a C57BL/6J background [C57BL/6J-
Tg(Thy1–APPK670N;M671L)]. To generate APP23 mice on a murine
App-null background, hemizygous APP23 mice were bred with C57BL/
6J–App mice (Calhoun et al., 1999). The resulting APP23/App/ mice
were bredwith APP23/App/ to obtain the desired APP23/App/ line.
Hemizygous R1.40 APP Tg mice on a B6.129 background were pur-
chased from The Jackson Laboratory. The mice carry a yeast artificial
chromosome containing the genomic copy of human APP harboring the
K670N–M671L mutation (Lamb et al., 1997). The mice were bred once
with C57BL/6J mice; then homozygous R1.40 mice were generated by
crossbreedings, resulting in homozygous mice on a B6.129/C57BL/6J
background. C57BL/6J mice were purchased from The Jackson Labora-
tory. All inoculations in the present study were done with homozygous
R1.40 mice and hemizygous APP23 mice. Female and male mice were
used in all experiments with the exception of the results presented in
Figure 3 for which only male mice were used. When males and females
were used, care was taken that groups had a similar number of males and
females. As indicated in the individual figure legends, male and female
mice were combined because either statistical analysis did not reveal a
significant difference or numbers were too small to do proper statistical
gender analysis. Overall, the induction of amyloid appeared somewhat
higher in females compared with males. All mice were maintained under
specific pathogen-free conditions. The experimental procedures were
undertaken in accordance with the veterinary office regulations of
Baden-Wu¨rttemberg (Germany) and approved by the local animal care
and use committees.
Brain tissue extracts. Brains from aged (18–30 months old) male and
female Tg APP23 and APPPS1 donor mice or age-matched, non-Tg
[wild-type (WT)] mice of our APP23 or APPPS1 colonies were used
(Sturchler-Pierrat et al., 1997; Radde et al., 2006). After the cerebellum
and lower brainstemwere removed, the forebrains were frozen on dry ice
and stored at 80°C. Brains were individually homogenized at 10%
(w/v) in sterile PBS (Lonza), vortexed, sonicated three times for 5 s (Lab
Sonic; B. Braun; 0.5-mm-diameter sonotrode, cycle 1, amplitude 80%)
and centrifuged at 3000  g for 5 min. The supernatant was aliquoted
and stored at80°C until use. A levels in extracts prepared from indi-
vidual brains were determined using electrochemiluminescence-linked
immunoassay and/or immunoblotting as described previously and re-
vealed total A concentrations of 10–20 ng/l in the Tg extract (Eisele et
al., 2009). Aliquots of several extracts (from at least three animals, Tg or
WT, respectively) were thawed just before intraperitoneal injections and
mixed to yield large batches of Tg or WT seeding extracts. All injected
extracts were derived from aged APP23 Tg mice but occasionally also
contained a minor amount (10% v/v) of extract derived from aged
APPPS1 Tg mice. [Note that adding such a minor amount of APPPS1
extract was shown to yield similar induction of cerebral-amyloidosis as
pure APP23 seeding extract in APP23Tgmice (Eisele et al., 2010) and has
no major influence on the A40/A42 ratio of the seeding extract mix.]
Intraperitoneal inoculation. Mice received two intraperitoneal injec-
tions of 100l of Tg extract orWT extract 1 week apart, unless indicated
otherwise. For the concentration-dependent study,mice received a single
intraperitoneal injection of 200 l of Tg extract or 1:10, 1:100, or 1:1000
PBS dilutions thereof. All mice were randomly assigned to the inocula-
tion groups.
Mixture of anti-A antibodies and Tg brain extract. Before the intra-
peritoneal inoculation, Tg extract was 2:1 mixed with 4.5 mg/ml of the
anti-A antibody 1 (monoclonal, mouse IgG2a; Meyer-Luehmann et
al., 2006). The mixing procedure results in a 6.7% extract. A total of 200
l of this mixture was intraperitoneally injected into APP23 hosts.
Preparation of inoculatedmice.APP23 Tgmice were prepared 1, 4, 6, 7,
and 8months after inoculation without perfusion. APP23 Tgmice on an
App-null background (APP23/App/) were prepared 8 months after
inoculation. Brains were removed, and right hemispheres were directly
frozen on dry ice for biochemical analysis and stored at 80°C. Left
hemispheres were immersion fixed in 4% paraformaldehyde in PBS for
48 h, cryoprotected in 30% sucrose, frozen in 2-methylbutane, and
stored at80°C until analysis. R1.40 mice, which normally develop A
pathology later in life than doAPP23mice (Hamaguchi et al., 2012), were
prepared 1, 6, 8, 10, and 12months after intraperitoneal injections. R1.40
mice were killed under deep ketamine/xylazine anesthesia (400 mg/kg
ketamine, 40 mg/kg xylazine) and transcardially perfused with PBS. The
brains were harvested and hemi-dissected. Right hemispheres were again
directly frozen, and the left hemispheres were immersion fixed. Periph-
eral organs were also taken when indicated and immersion fixed in 4%
paraformaldehyde, followed by paraffin embedding.
Histology and immunohistochemistry. Fixed frozen brains were cut into
25-m-thick coronal sections using a freezing-sliding microtome.
Paraffin-embedded tissue was cut into 6-m-thick sections on a rotary
microtome (Microm HM 325), and a previously published enhanced
antigen retrieval technique was used (Kai et al., 2012). All sections were
A immunostained using polyclonal antibody CN3 (1:1000; raised
against residues 1–16 of human A; Eisele et al., 2010) and visualized
using standard immunoperoxidase procedures with the Vectastain Elite
ABC kit (Vector Laboratories). After immunohistochemistry, some sec-
tions were additionally stained with Congo red and visualized between
cross-polarizers and/or counterstained with nuclear fast red. To analyze
the integrity of the blood–brain barrier, sections were immunostained
with antibodies against mouse IgG (1:250; Vector Laboratories) and
mouse albumin (rabbit polyclonal, 1:1000; Thermo Fisher Scientific).
Visualizationwas done as described above. ThePrussian blue histological
stain with nuclear fast red counterstaining was used to visualize ferric
iron in hemosiderin and performed as described previously (Winkler et
al., 2001).
Immunoblot and immunoassay for APP and A. Right brain hemi-
spheres were homogenized at 10% (w/v) in homogenization buffer [in
mM: 50 Tris, pH 8.0, 150 NaCl, 5 EDTA, and Complete Mini protease
inhibitormixture (Roche)]. To assess A andAPP levels, 4–12%NuPage
Bis-Tris mini gels using NuPage LDS sample buffer were used (Invitro-
gen), followed by protein transfer onto nitrocellulose membranes and
probing with antibody 6E10 (Covance). Monoclonal anti-GAPDH anti-
body (Hy Test) was used to detect the housekeeping protein GAPDH.
Densitometric values of band intensities were analyzed using NIH
ImageJ 1.44 (http://rsbweb.nih.gov/ij/).
For electrochemiluminescence-conjugated immunoassay, 500 l of
homogenized brain sample (10% w/v in PBS) was extracted with an
equivalent volume of 0.4% diethylamine (DEA) and centrifuged at
135,000  g for 1 h at 4°C. A total of 850 l of the supernatant was
neutralized with 85 l of 0.5 M Tris-HCl, pH 6.8, to obtain the DEA-
soluble fraction. The DEA-insoluble pellet was resuspended to 500 l
volume with 70% formic acid (FA), incubated at 4°C for 12 h, and then
sonicated for 35 s at 4°C. The samples were analyzed on a Sector Imager
6000 using the MSD 96-well Multi-Spot Human 6E10 A Triplex Assay
(Meso Scale Discovery).
Quantification of A load on brain sections. The areal density of A-
immunoreactive lesions (CN3 staining) and Congo red staining was
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quantified in random-systematic sets through the neocortex according to
four categories: (1) CN3-positive vascular; (2) CN3-positive parenchy-
mal; (3) Congo red-positive vascular; or (4) Congo red-positive paren-
chymal. For APP23 Tg and APP23/App/mice, every 24th section was
assessed. TheA load (%A-immunostained area) of R1.40 Tgmicewas
lower compared with the APP23 mice, and thus every 12th section
was assessed. Stereological analysis was performed using a Zeiss Axios-
kop microscope equipped with a motorized x–y–z stage coupled to a
video-microscopy system and the Stereo Investigator software (Micro-
BrightField). Quantification was performed by researchers who were
blinded to the inoculation groups.
Distance distribution analysis of parenchymal amyloid plaques. Mosaic
images of entire brain sections were acquired with a Zeiss Axioplan Mi-
croscope (MosaiX module, Zeiss AxioVision software) and imported in
Fiji (http://fiji.sc/Fiji). A systematically sampled set of every 12th coronal
section throughout the brain was imaged and analyzed as described pre-
viously (in total12 sections per animal).
A macro was written in Fiji to automate plaque recognition in a user-
selected region of interest (ROI). An experienced scientist manually se-
lected the ROI corresponding to the cerebral cortex, and care was taken
to exclude ambiguous structures and vascular amyloid from the ROI.
CN3-stained plaques were segmented using the luminance of the im-
ported image (L channel of the CIELAB color space, readily available in
Fiji as a plugin) and applying the RATS (Robust Automated Threshold-
ing Selection) plugin available in Fiji (Wilkinson, 1998). In addition, the
watershed transformation was used to split touching objects, improving
the plaque segmentation. After completion, the area of each plaque in
square micrometers was obtained, as well as its x–y centroid coordinates
andmajor andminor axes of a fitted ellipse. The plaqueswere assumed to
have a circular profile, the diameter of which was obtained by averaging
the sumof themajor andminor axes of the fitted ellipse. The assumption
of the circular shape was empirically confirmed not to have an effect on
the overall results of the analysis.
Pairwise two-dimensional Euclidean distances were calculated be-
tween the surface of each plaque and every other plaque in the ROI, using
the x–y coordinates and the circular diameter obtained by the image
recognition macro:
dij   xi  xj	2   yi  yj	2  ri  rj,
where dij indicates the surface-to-surface distance between two plaques, i
and j, plaque i has center coordinates (xi, yi) and circular diameter ri. The
calculations were performed using a program written in Fortran 77. The
program calculates the number of neighbors within set distances of
the plaque surface, for each plaque, based on the Euclidean distances
(above equation), to quantify the local spatial arrangement of the struc-
tures of interest (Hefendehl et al., 2014).
To investigate the number of small amyloid deposits around plaques
of various sizes, identified plaques were empirically assigned to four cat-
egories, according to their area on the section (Table 1; see Fig. 4).
Plaques that had an area smaller than 20m2, corresponding to a diam-
eter of5 m, were excluded from the analysis.
Peritoneal lavage. Peritonealmonocytes/macrophages were isolated by
peritoneal lavage of two 5ml doses of ice-cold PBS at the time the animals
were killed. The recovered cell suspension was put on ice, and the cells
were isolated by centrifugation (300 g for 5 min; Kim et al., 1997). The
cell pellet was resuspended in PBS for additional analysis.
Blood collection. EDTA-anticoagulated whole-blood samples were
taken by cardiac puncture at the time the animals were killed. For
electrochemiluminescence-linked immunoassays and immunoblotting,
the blood samples were separated into plasma and the cellular pellet by
centrifugation for 5 min at 16,000 g at room temperature. The blood
pellets were resuspended in the plasma-equivalent volumes of 1 ho-
mogenization buffer [in mM: 50 Tris, pH 8.0, 150 NaCl, 5 EDTA, and
Complete Mini protease inhibitor (Roche)]. Samples were snap frozen
and stored at80°C until analysis.
A quantification in blood. For electrochemiluminescence-linked im-
munoassay, blood plasma was subjected to measurement without addi-
tional treatment. The resuspended blood pellet (see above) containing
the cellular components was treated with FA (minimum of 95%), soni-
cated for 35 s on ice, and centrifuged at 25,000  g for 1 h at 4°C.
Supernatants were neutralized (1 MTris base, 0.5 MNa2HPO4, and 0.05%
NaN3). A levels were determined in duplicates using the MSD 96-well
MULTI-ARRAYHuman (6E10) A40 and A42 Ultra-Sensitive Assay or
MULTI-SPOTHuman (6E10) A Triplex Assay (Meso Scale Discovery)
and read on a Sector Imager 6000 according to the instructions of the
manufacturer. Each sample was measured twice, and the mean was
taken. Levels below detection (depending on the experiment;5 pg/ml)
were taken as zero. Resuspended cells isolated by peritoneal lavage were
likewise subjected to FA treatment. For A detection by immunoblot-
ting, the resuspended blood pellet was subjected to immunoprecipitation
using anti-A antibody 6E10 (Covance) and Dynal paramagnetic beads
with sheep anti-mouse IgG (Invitrogen) as described previously (Meyer-
Luehmann et al., 2006).
Histochemical and immunohistochemical staining of cells from the blood
and peritoneal cavity. Blood films on Superfrost slides (R. Langenbrink,
Emmendingen, Germany) were air dried for 24 h at room temperature.
Cells were fixed usingmethanol/acetone (1:1) for 90 s and air dried again.
Cells obtained by peritoneal lavage were resuspended in PBS and sub-
jected to cytospin (Cytospin J; Thermo Shandon) using disposable single
cell funnels (JC320; Tharmac). Pappenheim’s stain (Giemsa’s solution,
May-Gru¨nwald’s solution; Merck) was used for the differentiation of
cells isolated from the blood and peritoneal cavity. For immunohisto-
chemical analysis, slides were preincubated in PBS containing 0.1% Tri-
ton X-100 (Sigma). In combination with Pappenheim’s stain, A
immunostaining (CN3 antibody) was performed using standard immu-
noperoxidase procedures with the Vectastain Elite ABC kit (Vector Lab-
oratories). Double labeling for A (CN3 antibody) andCD11b, CD45, or
CD68 (Serotec) was performed using standard immunofluorescence
procedures with goat anti-rabbit Alexa Fluor 568 and goat anti-rat Alexa
Fluor 488 secondary antibodies (Invitrogen). For staining with pFTAA
[pentamer formyl thiophene acetic acid (sodium salt), part of the
amyloid-binding class of luminescent conjugated oligothiophene (LCO)
dyes; Klingstedt et al., 2011], cytospins from peritoneal lavage were dried
at room temperature for 2 h and incubated with PBS for 10min. Staining
with pFTAA (1.5 mM in deionized water, diluted 1:1000 in PBS) was
performed as described previously (Klingstedt et al., 2011). The sections
weremountedwithVectashieldmountingmedium for fluorescencewith
DAPI (Vector Laboratories). Images were acquired on a Zeiss LSM
510Meta laser scanning confocal microscope using a 63/1.4 numerical
aperture oil-immersion objective (Axiovert 200M; Zeiss). The amyloid-
binding dye pFTAA was excited with the 488 nm laser line, and its emis-
sion was collected in the range of 505–550 nm. The dyes were imaged
sequentially.
Statistical analysis. All values are expressed as means 
 SEMs. The
statistical analyses were performed using GraphPadPrism (version 6.0)
and/or JMP 8, and results are detailed in the figure legends.
Results
Earlier and stronger amyloid induction in APP23 compared
with R1.40 Tg mice
APP23 and R1.40 mice at the age of 1–2 months were inoculated
with the same brain extracts derived fromeither aged non-TgWT
mice (WT extract) or A bearing brain extract derived from
APP23 and APPPS1 Tg mice (the extracts of the individual mice
were pooled; see Materials and Methods; Tg extract). All mice
received two intraperitoneal injections of 100 l each 1 week
Table 1. Classification of plaque size according to area on section
Area (m2) Minimum circular diameter (m2) Class
A 14000 133.5 Large
14000 A 4000 71.4 Medium
4000 A 800 31.9 Small
800 A 20 5.04 Very small
A 20 Excluded
A, Area.
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apart. For eachmouse line, five different time points were chosen
for the analysis: 1, 4, 6, 7, and 8 months after inoculation for
APP23mice and 1, 6, 8, 10, and 12months for R1.40Tgmice (Fig.
1A). For the APP23 line, the time points were chosen based on
our previous work in which we found induction of cerebral
-amyloidosis after 6 –7 months in this line (Eisele et al.,
2010). For R1.40 mice, we found in pilot experiments (data
not shown) that amyloid induction after intraperitoneal inoc-
Figure 1. Time course reveals earlier and stronger induction of cerebral -amyloidosis in APP23 versus R1.40 Tg mice with the same peripherally applied A-containing seeding extract. A,
Experimental design: 1- to 2-month-old male and female APP23 and R1.40 Tgmice were intraperitoneally injected (i.p. inj.; two times with 100l, 1 week apart) with brain extracts derived from
either aged non-Tgmice (WT extract) or aged A-depositing APP Tgmice (Tg extract). Brains of inoculated APP23mice were analyzed 1, 4, 6, 7, and 8months and brains of inoculated R1.40mice
at 1, 6, 8, 10, and 12 months after inoculation [incubation (inc.)]. Male and female mice were combined for the analysis (see Material and Methods). B–E, Immunohistochemical analysis for A
deposition. B, In intraperitoneally inoculated APP23 mice, the first A deposits were noted at 6 months and increased sharply with the longer incubation times of 7 or 8 months. In contrast, mice
that received the WT extract and were incubated for 8 months showed no or very few A deposits, which are typical for APP23 Tg mice at 8–10 months of age, which is the age at analysis.
Stereological quantification of neocortical A load is shown in C. In R1.40 Tgmice, the first A deposits occurred 8months after inoculation in all mice that received the Tg extract albeit to aminor
extent and increases with longer incubation times of 10 or 12 months. In contrast, mice that received the WT extract showed no or very little A deposits after a 12 month incubation (D) that is a
typical finding for R1.40 Tgmice at 10–14months of age, which is the age at analysis. Stereological quantification of neocortical A load is shown in E. n 5–9 for APP23 and R1.40 Tgmice per
incubation time and extract; ***p0.001, ****p0.0001, one-wayANOVA, Bonferroni’spost hoc test. Scale bar, 200m.F, Neocortical Adeposits in both lineswere further differentiated into
vascular and parenchymal deposits, and results revealed that, in APP23 Tgmice, the majority of deposits (measured by area occupied) are parenchymal deposits with a high variability for vascular
deposits. Interestingly, in R1.40mice, vascular deposition seemedprominent during early timepoints but decreased thereafter andparenchymal deposits becamemoredominant.G, Differentiation
of the neocortical A deposits into congophilic (Congo red positive) and non-congophilic deposits revealed that, in APP23 Tg mice, 5–15% of induced deposits are congophilic, whereas in R1.40
mice, almost exclusively diffuse deposits are induced at least up to 12months incubation. (However, note that Congo red stains only the core of a plaque and thus the area fraction is low compared
with the A stain of a given amyloid plaque.) H–K, Biochemical analysis of brains 1 month after inoculation. Representative immunoblot for APP, differentiated into mature APP (APPm) and
immature APP (APPim) aswell as C99 levels, both recognized by the 6E10 antibody specific to human APP (H ). Relative APP levels (APPmand APPim combined)were quantified from immunoblots
and normalized to the housekeeping protein GAPDH.MeanAPP value forWT extract-injectedAPP23 Tgmicewas set to 100%.Quantification shows no difference betweenAPP23mice injectedwith
WT or Tg extract. Similarly, no difference was found in R1.40 mice. However, APP levels in R1.40 Tg mice were lower than in APP23 Tg mice representing30% of APP levels of APP23 mice (I ).
Overall, similar results were found for C99 levels (J ). HumanA levels in brain homogenateswere assessedwith electrochemiluminescence-linked immunoassay, and again, similar to APP and C99
levels, human A levels did not differ betweenmice of the same Tg line treated with either WT or Tg brain extract. Between the two lines, human A levels in APP23mice are significantly higher
and are approximately threefold to fourfold in APP23 comparedwith R1.40mice (K ). n 8 for APP23; n 5 for R1.40. Note that the same animals (1month incubation)were used for biochemical
analysis and histology. *p 0.05, ***p 0.001, ****p 0.0001, one-way ANOVA, Sidak’s multiple comparison test. nctx, Neocortex.
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ulation is only scarce after 8 months, and thus longer time
points were chosen.
For the inoculated APP23 mice, no induced A deposits in
brain were found at 1 and 4 months after inoculation. However,
robust induction of cerebral -amyloidosis with the Tg extract
was found 6 months after inoculation with a time-dependent
increase thereafter (Fig. 1B,C). Notably, WT extract did not in-
duce cerebral -amyloidosis at any time points (Fig. 1C). In the
intraperitoneally inoculated R1.40 mice, cerebral -amyloidosis
was detectable for the first time at 8months after inoculationwith
the Tg extract and further increased with longer incubation times
(Fig. 1D,E). Similar to APP23 hosts, WT extract did not induce
A deposits in R1.40 mice (Fig. 1E). Although the histological
quantification revealed 1.3-fold more induced A deposition in
the APP23 host (after the 8 months incubation) compared with
the R1.40 host (after the 12 months incubation; Fig. 1C,E), a
quantitative immunoassay detected 45-fold more insoluble A
(A40 and A42 combined) in the inoculated APP23 compared
with the inoculated R1.40 mice [2877.9 
 473.0 vs 61.6 
 14.6
ng/ml 10% (w/v) brain homogenate]. The apparent discrepancy
is likely related to the essentially diffuse nature of the induced
deposits in the R1.40mouse line, whereas the induced A depos-
its in the APP23 host were more frequently compact and congo-
philic (Fig. 1G).
In addition to parenchymal deposits, vascular A deposits
were induced in both lines (Fig. 1F). Although the relative per-
centage of induced amyloid around the vasculature was greatest
at early time points in the R1.40 mice and decreased thereafter,
this observation was not evident for the APP23 mice in the pres-
ent experiment, in contrast to our previous study (Eisele et al.,
2010). Interestingly, both lines showed prominent and early A
deposits in leptomeningeal vessels when inoculated with the Tg
extract in contrast to inoculations withWT extract in which such
deposits were absent.
We next analyzed human APP levels and APP processing 1
month after inoculation in APP23 and R1.40 mice to assess po-
tential short-term effects of intraperitoneal inoculations with the
Tg extract comparedwith theWT extract.Moreover, this allowed
for a direct comparison of human (Tg) APP protein expression in
both lines and thus may explain the different seeding efficacies
between the two host lines. Immunoblot analysis revealed no
difference in APP levels or levels of its C99 fragment between Tg-
and WT-inoculated mice for both mouse lines (Fig. 1H). When
comparing APP23 with R1.40 Tg mice, APP and C99 levels were
twofold to threefold higher in APP23 Tg mice compared with
R1.40 mice (Fig. 1 I, J). This is in line with the previous work
reporting a fivefold to sevenfold overexpression of human APP
over murine APP in hemizygous APP23 Tg mice (Sturchler-
Pierrat et al., 1997) and a twofold to threefold overexpression of
human versusmurine APP in homozygous R1.40 Tgmice (Lamb
et al., 1997). Consistent with the expression of APP and C99, an
immunoassay did not reveal any difference in “total” A (here
defined as A40 plus A42) between WT and Tg extract inocu-
lated APP23 or R1.40 mice at this early time point (Fig. 1K). In
comparison, human A levels in APP23 Tg mice were approxi-
mately threefold higher than in R1.40 Tg mice, paralleling the
difference in APP and C99 levels (Fig. 1K). These results suggest
that the stronger amyloid induction in APP23 compared with
R1.40 mice after intraperitoneal inoculation with the same A-
containing brain extract is related to the higher APP overexpres-
sion and higher A levels in APP23 brains.
To exclude that blood–brain barrier disruption was responsi-
ble for the observed phenomenon, we next analyzed whether we
could detect mouse IgG, mouse albumin, or microhemorrhages
in brains of intraperitoneally seeded APP23 and R1.40 mice. Re-
sults did not reveal evidence for blood–brain barrier damage at
any of the investigated time points after intraperitoneal inocula-
tion, with the exception of albumin staining associated with the
induced (congophilic) amyloid deposits. However, the latter also
prominently occurs in aged APP23 mice and to a lesser extent in
aged R1.40 mice because most of the amyloid deposits in R1.40
mice are of a diffuse nature (data not shown).
Cerebral beta-amyloidosis induction does not require
peripheral APP expression
Both Tg mouse lines used express endogenous murine APP in
brain and in the periphery (R1.40 additionally express peripheral
human APP). To study a possible effect of peripheral APP/A on
Figure 2. Induction of cerebral-amyloidosis by intraperitoneal seeding in the absence of
peripheral APP expression. A, Male and female APP23 mice and APP23 mice on an App-null
background (APP23/App/; all 1–2 months of age) were intraperitoneally inoculated with
200l of brain extract from aged A-depositing APP23 mice (Tg extract) or non-Tg WT mice
(WT extract) and analyzed for cerebral A deposition 8 months later. Male and female mice
were combined for the analysis (see Material and Methods). Shown are representative coronal
sections (scale bar, 500m), and higher-magnification images of the frontal cortex are shown
below (scale bar, 100m). Immunohistochemical analysis revealed a similar, albeit somewhat
lower, induction of A deposition by the Tg extract in APP23/App/mice comparedwith the
APP23mice.Mice that received theWT extract showed no induced A deposits. Note that 9- to
10-month-old APP23 andAPP23/App/mice (age at preparation) do exhibit the first endog-
enous A deposition at this age. B, Stereological quantification indeed revealed that the am-
yloid load of APP23/App/was 29% less compared with APP23 mice, but the difference
did not achieve significance (n  4 for APP23 mice and APP23/App/ mice injected
with WT extract and n 8 for APP23/App/ inoculated with Tg extract; mean
 SEM;
one way ANOVA, F(2,13) 6.136, p 0.013, Tukey’s multiple comparison, *p 0.05;
n.s., not significant). C, Neocortical A load was differentiated into vascular and paren-
chymal deposits. No difference was noted between APP23 and APP23/App/ mice. D,
Differentiation of neocortical amyloid in congophilic (Congo red positive) and non-
congophilic A lesions also revealed a similar distribution of deposits in both APP23 and
APP23/App/ Tg mice. nctx, Neocortex.
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cerebral amyloid induction, APP23mice and APP23 on amurine
App-null background (APP23/App/) were peripherally in-
jected with Tg extract and analyzed 8 months after inoculation
(Fig. 2). Results revealed qualitatively similar neocortical am-
yloid induction in both mouse lines (Fig. 2A,B). Quantitative
analysis indicated that the induction in the APP23 host lacking
murine APP was 29% lower compared with the induction in
the APP23 host, although this difference was not significant
(Fig. 2C). Because virtually the same difference (25%) in en-
dogenous cerebral -amyloidosis (measured as percentage
A-immunostained area as assessed in the present study) be-
tween APP23 and APP23 on a murine App-null background
was found (J. Mahler, B. M. Wegenast-Braun, J. Morales-
Corraliza, P. Mathews, and M. Jucker, unpublished observa-
tions), this indicates that higher amyloid load in APP23 Tg
mice is likely attributable to murine A co-depositing with
human A in the brain. The present observations in APP23 Tg
mice on App-null background indicate that peripheral
APP/A is not required for the intra-
peritoneal induction of cerebral
-amyloidosis.
Concentration-dependent induction of
cerebral-amyloidosis and efficient
blocking with anti-A antibody
Although our standard inoculation pro-
tocol consisted of two injections of 100 l
of brain extract given 1 week apart, we
wondered whether a single inoculation of
200 l of Tg brain extract and dilutions
thereof were also sufficient for the induc-
tion of A deposition. Moreover, to sus-
tain that A in the Tg extract is key for the
amyloid-inducing activity, Tg extract was
mixed with an A-specific antibody (1)
that has been shown previously to block
seeding during intracerebral injection of
the Tg extract (Meyer-Luehmann et al.,
2006). The APP23 host was selected, and
the inoculated mice survived for an 8
month incubation period. Results re-
vealed that the one-time inoculation was
comparable in all aspects with the inocu-
lations separated by 1 week (Fig. 3 com-
pared with Fig. 1). Although the 1:10
dilutions revealed approximately one-
sixth of the induction observed with the
undiluted extract, no detectable amyloid
deposits were induced by the 1:100 and
1:1000 dilutions within the observation
period, respectively (Fig. 3C). Strik-
ingly, the 1:10 extract dilution induced
predominantly vascular A deposits
(Fig. 3B,F ), a phenomenon also ob-
served in our previous study in intra-
peritoneally seeded APP23 Tg mice after
6 –7 months of incubation (Eisele et al.,
2010). Tg extract mixed with the 1 an-
tibody primarily prevented amyloid in-
duction (Fig. 3A,B), suggesting that the
induction of cerebral -amyloidosis is
dependent on the concentration of A
seeds in the intraperitoneally inoculated Tg extract.
Distribution characteristics of the induced cerebral
A deposits
In APP23 mice, intraperitoneally induced cerebral A deposits
were much more abundant in the frontal cortex, followed by the
entorhinal cortex, parietal cortex, hippocampus, and then other
brain regions (Fig. 4A). This was also true for the R1.40 line (data
not shown)matching the normal endogenous distribution of A
deposition in aged APP23 and R1.40 mice (Sturchler-Pierrat et
al., 1997; Kulnane and Lamb, 2001).
Closer examination revealed that, for all intraperitoneally in-
oculated mice, independent of inoculation time and host line,
there was appreciable clustering of parenchymal A deposits
throughout the brain (Fig. 4B). Typically large A plaques, in
most cases congophilic, were surrounded by a myriad of smaller
A deposits (Fig. 4C). On numerous occasions, vascular ele-
ments were observed in the center of the clusters.
Figure 3. Concentration-dependent induction of cerebral-amyloidosis by intraperitoneal seedingwith A-containing brain
extract in APP23mice. A, Tg extract and PBS dilutions 1:10 and 1:100 thereof (200l) were intraperitoneally injected into young
1- to 2-month-old APP23mice. Control micewere inoculatedwith 200l of brain extract from non-TgWTmice (WT extract). The
last group received a Tg extract that was mixed with the anti-A-specific antibody1 before the injection. All mice were males.
Brains were immunohistochemically analyzed for A deposition 8 months after intraperitoneal injection. Shown are representa-
tive coronal sections (scale bar, 500m), and higher-magnification images of the frontal cortex are shown below (scale bar, 100
m). The undiluted Tg extract induced the expected A deposition (see also Fig. 1B). The 1:10 diluted Tg extract induced
appreciable amyloid deposition, whereas the 1:100 diluted Tg extract did no longer induce noticeable A deposits (the samewas
true for the 1:1000 dilution; data not shown) and was identical to the WT extract-injected mice. Amyloid deposition in mice that
received the extract/1 mixture was markedly reduced. Note that some endogenous A plaques are typical for 9- to 10-month-
old APP23mice (age at analysis).B, Stereological quantification of neocortical A load, n 3–4mice per group; for the analysis,
the 1:100 and 1:1000 dilutionswere combined;mean
 SEM is indicated). C, Neocortical A loadwas differentiated into vascular
and parenchymal deposits. Although the majority of A deposits induced by the undiluted Tg extract were detected in the brain
parenchyma, deposition induced by the 1:10 diluted Tg extract showed prominent percentage of vascular deposits.D, Neocortical
amyloid load was differentiated in congophilic (Congo red positive) and non-congophilic A deposits revealing that the induced
A deposits are primarily of a diffuse nature. (However, note that Congo red stains only the core of a plaque and thus the area
fraction is low comparedwith theA stain of a given amyloid plaque.) The increasedpercentage of Congo red staining in the 1:100
dilution group represents the endogenous A plaques. nctx, Neocortex; undil, undiluted.
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To sustain this qualitative observation of clustering of the
induced A deposits, the localized distribution of A deposits
between intraperitoneally seeded and aged (nonseeded) APP23
Tg mice was investigated. A nearest-neighbor algorithm was ap-
plied on sections calculating the Euclidean distances between sur-
faces of plaques (Fig. 4D–F). The resulting quantification
confirmed that, in intraperitoneally seeded APP23 mice, larger
plaques had a substantially higher number of smaller plaques/A
deposits in their close vicinities compared with the endogenous
plaques in nonseeded aged APP23 Tg mice (Fig. 4D–F).
Thus, despite the similar overall regional distribution of A
plaques throughout the brain, quantification of the micro-
distribution revealed more clustering of the amyloid deposits af-
ter intraperitoneal induction compared with aged nonseeded
APP23 Tg mice.
Peripherally injected A seeds are detectable shortly after
injections in macrophages in the peritoneal cavity, blood,
liver, and spleen
To get additional hints toward the mechanism by which intra-
peritoneally applied A-containing brain material induces cere-
bral-amyloidosis, APP23micewere given single intraperitoneal
injections of 200l of Tg orWT extract and killed within the first
24 h, one week, or 1 month after injection with subsequent anal-
ysis of the peritoneal cells, blood, peripheral organs, and brain.
Analysis of the cellular fraction isolated by peritoneal lavage
by immunoassay revealed that 2% of the injected human A
(Tg extract) could be recovered within peritoneal monocytes at 3
and 24 h after inoculation (Fig. 5A,B). After 1 week, some of the
injected Awas still detectable (Fig. 5A,B). Similarly, human A
was detected in blood monocytes (CD11b and CD45 positive) in
the Tg but not WT extract-injected mice, again peaking within
the first 24 h after inoculation (Fig. 5C–E). In agreement, immu-
noblotting of the cellular blood fraction confirmed the presence
of human A (Fig. 5F). No change in blood plasma human A
levels was found at any examined time points (data not shown).
Interestingly, A taken up by peritoneal monocytes stained with
the amyloid-specific dye pFTAA, indicating that at least some of
it is aggregated and in -sheet structure (Fig. 5G). A-positive
macrophages were also detected in the liver 1 d after the inocula-
tion with the Tg extract (Fig. 5H) and only occasionally after 7 d.
A-positive staining of cellular and extracellular elements was
found at 1 d after inoculation also in the spleen (data not shown).
Consistent with previous work (Eisele et al., 2010), no A depo-
sition was found or induced in the examined peripheral tissues of
APP23 mice (and also R1.40 mice) at 8 and 12 months after
inoculation, respectively.
Discussion
We recentlymade the surprising observation that intraperitoneal
inoculation of A seed-containing brain extract induced cerebral
-amyloidosis in APP23 Tg mice (Eisele et al., 2010). A similar
observation has just been described for Tau, i.e., the intraperito-
neal administration of Tau aggregates was found to induce Tau
lesions in Tau Tg mice (Clavaguera et al., 2014). In the present
study, we further characterized the peripheral induction of cere-
bral-amyloidosis and provide evidence formultiple brain entry
sites of the A seeds and self-propagation in brain. No evidence
for peripheral amyloid formation was found even in mice ex-
pressing human APP systemically.
Intraperitoneal inoculation with A-containing brain extract
induced cerebral -amyloidosis in all three APP Tg mouse lines
used as hosts, i.e., APP23 mice, APP23 mice on App-null back-
Figure 4. Regional distribution of intraperitoneally induced cerebral-amyloidosis resem-
bles endogenous amyloid deposition, albeit the induced amyloid deposits appear more clus-
tered. A, Intraperitoneally injected A seeds predominantly induce A deposits in the frontal
cortex, followed by the parietal cortex and the hippocampus. Shown is a sagittal section of an
APP23 mouse 8 months after the intraperitoneal inoculation. Stereological quantification of
systematically sampled coronal sections (every 24th was taken) throughout the brain revealed
a similar anterior-to-posterior distribution of plaque load in intraperitoneally seeded APP Tg
mice compared with nonseeded APP23 Tg mice. For the analysis, five intraperitoneally seeded
mice (7–8months after inoculation; plaque load, 0.90
 0.09) were compared with five aged
APP23micewith a similar plaque load (12–14months old; plaque load, 0.84
0.25).Male and
female mice were combined for the analysis (see Material and Methods). In the diagram, the
mean
 SEM is shown.B, Coronal sections through an APP23 Tgmouse brain intraperitoneally
inoculated with Tg extract and incubated for 8 months. Note the clustering of the induced A
deposits (arrowheads). This is most evident in the posterior sections in which the induced
amyloid load is less extensive compared with the anterior sections. Scale bar, 1000 m. C,
Higher magnification of clustered A deposits, in which typically a large plaque was sur-
rounded by numerous smaller A deposits. Shown is a representative image of an APP23 Tg
mouse 8 months after inoculation and an R1.40 mouse 12 months after inoculation. D–F,
Quantitative analysis of clustering of A deposits. A deposits were quantified in size [blue for
large (L), green formedium (M), yellow for small (S), and red for very small (XS)], and their x–y
position was determined (for details, see Materials andMethods); an example is shown for the
entorhinal cortex for intraperitoneally seededandnonseededAPP23Tgmice (D). The frequency
distribution of the XS deposits (20–800m2) around larger deposits (800m2), within
100m from their surface, revealed higher numbers of the XS deposits surrounding the larger A
deposits in intraperitoneally seeded APP23 Tg mice compared with nonseeded APP23 Tg mice (E).
DifferentiationbetweenXSplaques surroundingL,M,andSplaqueswithin20,50,and100mfrom
thesurfaceyieldedasignificant increase in thenumberofXSneighboringplaques in intraperitoneally
seeded APP23 Tg mice. However, the increase was most pronounced around the L and M plaques.
Additionally, an increase of the number of neighbors around plaques of all sizes was evident in the
intraperitoneally seededanimalsas thedistance to theplaquesurface increased.Thedifference in the
number of neighbors between nonseeded and seeded animals, for any plaque size, was significant
(p 0.001,Mann–Whitney test); darker-to-lighter box shading denotes 20, 50, and 100mfrom
plaque surface, respectively, for each category (L,M, S); box hinges are 25th–75th percentiles,whis-
kers are adjacent values, andpoints are outliers. Scale bars:C,D, 200m.
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ground, and R1.40 mice (Lamb et al., 1997; Sturchler-Pierrat et
al., 1997; Calhoun et al., 1999). Interestingly, the induction was
earlier and stronger in APP23 than in R1.40 host. This is consis-
tent with the approximate fivefold to sevenfold overexpression of
human APP in the brain of APP23 mice (Sturchler-Pierrat et al.,
1997) in contrast to the threefold overexpression of human APP
in the R1.40mice (Lamb et al., 1997). The result suggests that the
availability of soluble A peptides in brain plays a major role in
the induction of cerebral amyloidosis by peripheral (intraperito-
neal) inoculation of A seeds. This is also supported by the ob-
servation that the peripherally induced amyloid distribution in
brain reflected the endogenous distribution in both lines.
Mixing of antibody against A to the brain extract before
intraperitoneal injection greatly diminished induction of cere-
bral -amyloidosis, and no induction was observed with intra-
peritoneally inoculated WT extract. These data are consistent
with previous observations for intracerebral seeding (Meyer-
Luehmann et al., 2006) and show that A peptides are essential
for the induction of cerebral -amyloidosis in contrast to gener-
alized reactions to the inoculation (e.g., inflammation, stress re-
sponse). The present findings also indicate that relatively large
amounts of A seeds are needed to initiate cerebral
-amyloidosis by intraperitoneal seeding. Positive results were
obtained after injection of extracts containing 400 ng of total
A (1:10 dilution of Tg extract), indicating that intraperitoneal
seeding is 1000-fold less potent than intracerebral seeding
(Eisele et al., 2009; Langer et al., 2011). However, it should be
noted that peritoneal inoculation starts plaque seeding in all cor-
tical areas, whereas intracerebral seeding acts locally at the site of
injection, e.g., the hippocampus or other brain regions (Eisele et
al., 2009).
No induction of A deposits in any peripheral tissue of the
R1.40 mice was found despite the fact that R1.40 mice overex-
press human APP in the periphery (Lamb et al., 1997). No amy-
Figure 5. Intraperitoneally injected A seeds are detectable shortly after the injection in
macrophages in the peritoneal cavity, blood, liver, and spleen. A, Electrochemiluminescence-
conjugated immunoassay for human A (A40 and A42 combined) in the cellular fraction of
the peritoneal fluid 3 h, 24 h, 1week, or 1month after intraperitoneal inoculationwith Tg orWT
extract. Male or female 4- to 8-month-old APP23mice, n 5 per group and time point except
n 4 for the 1month time point. Separate statistical analysis did not indicate a gender or age
difference. ANOVA revealed significant main effects and a significant extract  post-
inoculation time interaction (F(3,30) 14.02; p 0.001). Post hoc Tukey’s tests showed signif-
icantly more A in the Tg extract-treated mice at 24 h compared with 3 h ( p 0.05) and 1
week ( p  0.001). Wilcoxon’s comparisons revealed similar significances. Indicated is the
mean
 SEM. B, Pappenheim’s stain (purple) combined with A immunostaining (dark blue)
of lavaged peritoneal cells from a Tg extract-inoculated mouse disclosed A-positive
4
monocytes (arrowheads). No A immunoreactivity was found in WT extract-inoculated mice.
C, Electrochemiluminescence-conjugated immunoassay for human A in the blood cellular
fraction 1–24 h, 1 week, or 1 month after intraperitoneal inoculation. Male or female 4- to
8-month-old APP23 mice, n 16 (Tg extract) and n 11 (WT extract) for the 1–24 h time
point andn5per group for other timepoints. (Animalswere added to the1–24h timeperiod
in an unsuccessful effort to reduce the high variability of Ameasurements.) Separate statis-
tical analysis did not indicate a gender or age difference. ANOVA indicated no significant differ-
ences, butWilcoxon’s test revealed a significant difference between Tg extract-treated andWT
extract-treated mice in the 1–24 h post-inoculation group (median, 0.495 vs 0; p 0.05). D,
A-positivemonocytes (arrowheads) in a blood film from a Tg extract-inoculatedmouse (Pap-
penheim’s stain, purple; A immunostain, dark blue). E, Double-immunofluorescence staining
revealed that A-positive (red) cells are positive for CD11b and CD45 (green;maximumprojec-
tion of 10m z-stack). Scale bars, 10m. The same cells were also positive for CD68 (data not
shown). F, Immunoprecipitation of the blood cellular fraction with an antibody against human
A followed by immunoblot revealed a robust 4 kDa A band in Tg extract-inoculatedmice, as
well asweaker oligomeric Abands (indicated by asterisks) andAPP, very similar as seen in the
Tg extract (Langer et al., 2011). Only aweak signal corresponding tomonomeric Awas seen in
WT extract-inoculated mice, possibly because of residual human endogenous A from the
plasma fraction. IG heavy chain (HC) and light chain (LC) signals are attributable to coelution of
the antibodies used for immunoprecipitation. G, The amyloid-specific dye pFTAA stains A in
peritoneal monocytes isolated from Tg-extract inoculatedmice. DAPI is used as a nuclear coun-
terstain (scale bar, 5m).H, I, Peripheral organs of representativemicemeasured and stained
in (A–D) were immunostained for A and counterstained with nuclear fast red. A-positive
cells with the morphological characteristics of macrophages were found in the liver of Tg
extract-inoculated mice (n 3 analyzed mice) but not WT inoculated mice (n 2 analyzed
mice) 1 d after inoculation. Scale bar: 50 and 10m. In a separate study, non-Tg B6mice were
injected with Tg andWT extract (n 2 for Tg andWT each) and analyzed 1 h, 1 d, 1 week, and
1month later. Again, A-positive cells with amacrophagic appearancewere found after 1 and
7 d but not 1 month after inoculation (results not shown).
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loid induction in peripheral organs was also reported in APP23
mice (Eisele et al., 2010). Moreover, we observed efficient intra-
peritoneal seeding in APP23 mice on App-null background in
which even peripheral mouse APP is missing. These data suggest
that peripheral APP/A expression may not be required for
transmission of A seeds from the peritoneal cavity to the brain.
For Scrapie and other forms of transmissible spongiform enceph-
alopathies or prion diseases, replication of misfolded PrPSc in
peripheral tissues can occur before neuroinvasion (Brown et al.,
1999) and play a major role in the prion spread throughout the
infected organism (Aguzzi et al., 2013). In fact, peripheral PrPC
expression was found to be essential for clinical infection and
transmission of Scrapie to the brain of mice (Bla¨ttler et al., 1997).
However, more recently, diverse other routes have been reported
depending on the concentration or nature (conformation) of the
prions (Bett et al., 2012; Chen et al., 2014).
We aimed to follow the fate of the injected seeds and detected
traces of the injected Amaterial in monocytes/macrophages in
the peritoneal cavity, as well as in blood and tissue macrophages
of liver and spleen shortly after injection. A significant decrease of
this material was observed within 1 week, and it was below the
detection limit at 1 month after inoculation. The uptake and
degradation of A aggregates by cells of the monocyte lineage is
well documented (Majumdar et al., 2008; Zaghi et al., 2009; Lai
and McLaurin, 2012; Michaud et al., 2013). We have shown re-
cently that A seeds are partly proteinase-K resistant (Langer et
al., 2011), and insufficient clearance of A seeds within cells has
been shown to contribute to cell-to-cell spread of the seeds
(Domert et al., 2014). These observations may explain the persis-
tence of A-immunoreactive monocytes for at least 1 week after
intraperitoneal inoculation. Because peripheral phagocytes can
be recruited to enter the brain (Rezai-Zadeh et al., 2011; Varvel et
al., 2012) it is conceivable that they could serve to transport A
seeds from the periphery to the brain. However, it is also possible
that A seeds in blood plasma at levels below detection reach the
brain (Mackic et al., 2002; Deane et al., 2003). Of note, it has been
shown previously that AA amyloidosis can be transferred by
blood monocytes (Sponarova et al., 2008).
A closer look at the distribution of the induced deposits re-
vealed more clustering of intraperitoneally induced deposits
compared with normally aged mice with similar amyloid load in
APP23 Tg mice. This suggests that, in normally aged APP23 Tg
mice, possibly because of the high overexpression of humanAPP,
spontaneous aggregation occurs in many locations. In contrast,
the pattern of A aggregation in intraperitoneally seeded mice
suggests hot spots of induction with subsequent spreading to
areas in close proximity. It is tempting to speculate that the ob-
served prominent vascular -amyloidosis at early time points
and with the 1:10 diluted extract reflects the route of transport of
A seeds. The formation of clusters may suggest that A seeds
enter the brain at various vascular locations in which local A
misfolding is initiated that subsequently spreads within the brain
parenchyma. It is in agreement with the notion that corruptive
templating of host A occurs mainly in brain. Such a scenario
may also explain why we found in our initial work a striking
dominance of vascular amyloidosis after intraperitoneal inocula-
tion (Eisele et al., 2010). It underlines that the nature and location
of the induced A deposits may vary with incubation time, A
seeds, and potentially also between host mice.
In summary, the peripheral induction of cerebral
-amyloidosis in APP Tg mice is dependent on the amount of
inoculated A-containing brain extract and on the level of
APP/A expression in the brain. No amyloid induction was
found in peripheral organs. The induced A deposits in brain
occurred in a characteristic pattern consistent with the entry of
A seeds at multiple brain locations. Our results suggest that
intraperitoneally inoculated A seeds are transported from the
periphery to the brain in which corruptive templating of host A
occurs at multiple sites, most efficiently in regions with high
availability of soluble A.
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